Trial intelligence / Profile preview

Linaclotide in pediatric functional constipation (2-5 years)

NCT04110145Phase 2Completed

Sponsor
Allergan
Start
Oct 2019
Primary completion
Apr 2021
Modality
Peptides
Countries
1
01

Overview

A Phase 2 trial of linaclotide in functional constipation (FC), sponsored by Allergan. Started Oct 2019; status: completed.

02

Drugs

linaclotide
03

Conditions

functional constipation (FC)

Beyond the preview

Go deeper on NCT04110145.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04110145.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call